Liberian scientist and medical doctor, Dr. Dougbeh Chris Nyan is among a select group of twenty African innovators invited by the Government of Egypt to participate in the Africa 2017 Business Forum and the Young Entrepreneurs Day (YED) event.
The Egyptian Government and the Common Market for Eastern and Southern Africa (COMESA) invited Dr. Nyan to present his groundbreaking invention that detects and identifies three to seven infectious diseases in 10 to 40 minutes using one test.
The Africa Business Forum is a landmark event organized by the Ministry of Investment and International Cooperation of the Egyptian Government in conjunction with the Regional Investment Agency of COMESA. This year’s event will be held under the theme, “Business for Africa, Egypt and the World – Driving Investment for Inclusive Growth” and hosted in the Egyptian resort city of Sharm el-Sheikh from December 7 to 9.
The forum will draw 250 handpicked delegates, while the Africa 2017 YED will feature the rising entrepreneurial stars of the continent, who includes Dr. Nyan.
According to a dispatch, the event will also welcome leading private investment firms, visionary policymakers and a roster of farsighted African leaders who are currently changing the entrepreneurial ecosystem in Africa and the world.
According to the release, the 2017 African Innovation Special Prize Laureate, Dr. Nyan along with his company, Shufflex Biomed, is one of the select founders and young entrepreneurs that will engage in a series of entrepreneurial discussions with leading investment firms and multinational corporations.
Dr. Nyan, was recognized and invited by the Egyptian Government and the COMESA regional economic block for his groundbreaking invention.
According to biomedical experts, the “Nyan Test” is inexpensive and simple to use, and can be transported to inaccessible hard-to-reach rural settings. The test can detect diseases such as HIV/AIDS, West Nile virus, Ebola, Malaria, as well as Typhoid, Yellow fever and Tuberculosis, in less than an hour, whereas conventional methods take three hours to seven days to detect and identify one infection.
“At the moment, we are currently seeking funding and investment to facilitate the present stage of producing our second generation prototype of the test, conduct field trials in Africa and South America, obtain pre-market clearances in various regulatory jurisdictions, and get the diagnostic test ready for the market,” said Dr. Nyan, whose invention won the prestigious Africa Innovation Special Prize for Social Impact in July this year.
He further stated, “I am humbly requesting African governments and financiers to support the production of this diagnostic test for the people of Africa and the world. We Africans must support each other to find solutions to Africa’s enormous healthcare, socioeconomic problems,” Dr. Nyan said.
On July 26 this year during Liberia’s Independence Day, Dr. Nyan, in line with his pan-Africanist outlook, dedicated his award and invention to the peoples of Africa. For now, it remains to be seen how Liberia and the Economic Community of West African States (ECOWAS) will engage as Egypt and COMESA are apparently taking a promising and supportive lead on Dr. Nyan’s invention.